EIP
Easterly Investment Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,060
| Closed | -$367K | – | 202 |
|
|
2024
Q1 | $367K | Sell |
1,060
-15,597
| -94% | -$5.39M | 0.03% | 186 |
|
|
2023
Q4 | $5.38M | Sell |
16,657
-18,070
| -52% | -$5.83M | 0.58% | 64 |
|
|
2023
Q3 | $12.4M | Sell |
34,727
-9,319
| -21% | -$3.34M | 1.37% | 17 |
|
|
2023
Q2 | $16.7M | Buy |
44,046
+2,919
| +7% | +$1.11M | 1.48% | 16 |
|
|
2023
Q1 | $19.7M | Sell |
41,127
-28,350
| -41% | -$13.6M | 1.73% | 8 |
|
|
2022
Q4 | $29.2M | Buy |
69,477
+16,419
| +31% | +$6.9M | 2.52% | 2 |
|
|
2022
Q3 | $22.1M | Buy |
53,058
+3,601
| +7% | +$1.5M | 2.12% | 8 |
|
|
2022
Q2 | $24.5M | Buy |
49,457
+13,678
| +38% | +$6.77M | 2.18% | 6 |
|
|
2022
Q1 | $20.2M | Buy |
35,779
+33,907
| +1,811% | +$19.1M | 1.52% | 18 |
|
|
2021
Q4 | $1.41M | Buy |
1,872
+32
| +2% | +$24.2K | 0.1% | 126 |
|
|
2021
Q3 | $1.37M | Hold |
1,840
| – | – | 0.09% | 128 |
|
|
2021
Q2 | $1.19M | Hold |
1,840
| – | – | 0.14% | 57 |
|
|
2021
Q1 | $1.05M | Hold |
1,840
| – | – | 0.13% | 53 |
|
|
2020
Q4 | $1.07M | Sell |
1,840
-1,418
| -44% | -$827K | 0.15% | 51 |
|
|
2020
Q3 | $1.68M | Sell |
3,258
-9
| -0.3% | -$4.64K | 0.07% | 42 |
|
|
2020
Q2 | $1.48M | Sell |
3,267
-103,146
| -97% | -$46.6M | 0.07% | 43 |
|
|
2020
Q1 | $37.3M | Sell |
106,413
-57,745
| -35% | -$20.2M | 1.65% | 26 |
|
|
2019
Q4 | $60.7M | Sell |
164,158
-108,996
| -40% | -$40.3M | 1.71% | 27 |
|
|
2019
Q3 | $90.9M | Sell |
273,154
-368,654
| -57% | -$123M | 2.55% | 17 |
|
|
2019
Q2 | $201M | Buy |
641,808
+55,191
| +9% | +$17.3M | 5.04% | 1 |
|
|
2019
Q1 | $179M | Buy |
+586,617
| New | +$179M | 4.33% | 6 |
|